References
- Bousquet J, AllerGen, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 Suppl 86:8–160. doi:https://doi.org/10.1111/j.1398-9995.2007.01620.x.
- Eguiluz-Gracia I, Ariza A, Testera-Montes A, Rondón C, Campo P. Allergen immunotherapy for local respiratory allergy. Curr Allergy Asthma Rep. 2020;20(7):23. doi:https://doi.org/10.1007/s11882-020-00920-w.
- Papadopoulos NG, Guibas GV. Rhinitis subtypes, endotypes, and definitions. Immunol Allergy Clin North Am. 2016;36(2):215–233. doi:https://doi.org/10.1016/j.iac.2015.12.001.
- Campo P, Eguiluz-Gracia I, Bogas G, Salas M, Plaza Serón C, Pérez N, Mayorga N, Torres MJ, Shamji MH, Rondon C. Local allergic rhinitis: Implications for management. Clin Exp Allergy. 2019;49(1):6–16. doi:https://doi.org/10.1111/cea.13192.
- Campo P, Eguiluz‐Gracia I, Plaza‐Serón MC, Salas M, José Rodríguez M, Pérez‐Sánchez N, González M, Molina A, Mayorga C, Torres MJ, et al. Bronchial asthma triggered by house dust mites in patients with local allergic rhinitis. Allergy. 2019;74:1502–1510. doi:https://doi.org/10.1111/all.13775.
- Calderón MA, Linneberg A, Kleine-Tebbe J, De Blay F, Hernandez Fernandez de Rojas D, Virchow JC, Demoly P. Respiratory allergy caused by house dust mites: What do we really know?J Allergy Clin Immunol. 2015;136(1):38–48. doi:https://doi.org/10.1016/j.jaci.2014.10.012.
- Carney AS, Powe DG, Huskisson RS, Jones NS. Atypical nasal challenges in patients with idiopathic rhinitis: more evidence for the existence of allergy in the absence of atopy?Clin Exp Allergy. 2002;32(10):1436–1440. doi:https://doi.org/10.1046/j.1365-2745.2002.01465.x.
- Shin YS, Jung CG, Park HS. Prevalence and clinical characteristics of local allergic rhinitis to house dust mites. Curr Opin Allergy Clin Immunol. 2018;18(1):10–15. doi:https://doi.org/10.1097/ACI.0000000000000413.
- Pfaar O, Agache I, de Blay F, Bonini S, Chaker AM, Durham SR, Gawlik R, Hellings PW, Jutel M, Kleine-Tebbe J, et al. Perspectives in allergen immunotherapy: 2019 and beyond. Allergy. 2019;74 Suppl 108(Suppl 108):3–25. doi:https://doi.org/10.1111/all.14077.
- Vitiello G, Maltagliati L, Rossi O. New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ® tablets. Clin Mol Allergy. 2020;18(18):10. doi:https://doi.org/10.1186/s12948-020-00124-7.
- Sidenius K, Arvidsson P, Indbryn R, Emanuelsson CA. A real-life one-year non-interventional study assessing safety, tolerability, and treatment outcome of the SQ HDM SLIT-tablet (Acarizax®) in house dust mite allergic rhinitis with or without asthma. Pulm Ther. 2021; 7(1):221–236. doi:https://doi.org/10.1007/s41030-021-00150-z.
- Lawrence MG, Steinke JW, Borish L. Basic science for the clinician: Mechanisms of sublingual and subcutaneous immunotherapy. Ann Allergy Asthma Immunol. 2016;117(2):138–142. doi:https://doi.org/10.1016/j.anai.2016.06.027.
- Dhami S, Kakourou A, Asamoah F, Agache I, Lau S, Jutel M, Muraro A, Roberts G, Akdis CVA, Bonini M, et al. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis. Allergy. 2017;72(12):1825–1848. doi:https://doi.org/10.1111/all.13208.
- Boulet LP, Reddel HK, Bateman E, Pedersen S, FitzGerald JM, O’Byrne PM. The Global Initiative for Asthma (GINA): 25 years later. Eur Respir J. 2019;54(2):1900598. doi:https://doi.org/10.1183/13993003.00598-2019.
- Augé J, Vent J, Agache I, Airaksinen L, Campo Mozo P, Chaker A, Cingi C, Durham S, Fokkens W, Gevaert P, et al. EAACI Position paper on the standardization of nasal allergen challenges. Allergy. 2018;73(8):1597–1608. doi:https://doi.org/10.1111/all.13416.
- Hilberg O, Pedersen OF. Acustic rhinometry: recommendations for technical specifications and standard operating procedures. Rhinology. 2000;16:3–17.
- Eckrich J. Nasal IgE in subjects with allergic and nonallergic rhinitis. World Allergy Organ J. 2020;1–12.
- Nacleiro RM, Proud D, Kagey-Sobotka A, Adkinson NF, Jr, Meyers DA, Norman PS, Lichtenstein LM. Mediator release after nasal airway challenge with alergen. Am Rev Respir Dis. 1983;128:597–602.
- Corrado A, Ramonell RP, Woodruff MC, Tipton C, Wise S, Levy J, DelGaudio J, Kuruvilla ME, Magliocca KR, Tomar D, et al. Extrafollicular IgD + B cells generate IgE antibody secreting cells in the nasal mucosa. Mucosal Immunol. 2021;28:1–16.
- Bozek A, Kolodziejczyk K, Jarzab J. Efficacy and safety of birch pollen immunotherapy for local allergic rhinitis. Ann Allergy Asthma Immuniol. 2018;120(94):53–58.
- Rondón C, Blanca-López N, Aranda A, Herrera R, Rodriguez-Bada JL, Canto G, Mayorga C, Torres MJ, Campo P, Blanca M. Local allergic rhinitis: allergen tolerance and immunologic changes after preseasonal immunotherapy with grass pollen. J Allergy Clin Immunol. 2011;127(4):1069–1071. doi:https://doi.org/10.1016/j.jaci.2010.12.013.
- Rondón C, Campo P, Salas M, Aranda A, Molina A, González M, Galindo L, Mayorga C, Torres MJ, Blanca M. Efficacy and safety of D. pteronyssinus immunotherapy in local allergic rhinitis: a double-blind placebo-controlled clinical trial. Allergy. 2016;71(7):1057–1061. doi:https://doi.org/10.1111/all.12889.
- Emminger W, Hernández MD, Cardona V, Smeenk F, Fogh BS, Calderon MA, de Blay F, Backer V. The SQ house dust mite SLIT-Tablet Is Well Tolerated in Patients with House Dust Mite Respiratory Allergic Disease. Int Arch Allergy Immunol. 2017;174(1):35–44. doi:https://doi.org/10.1159/000478699.